Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) EPS (Weighted Average and Diluted) (2024 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed EPS (Weighted Average and Diluted) for 2 consecutive years, with $0.33 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 43.48% to $0.33 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.77 through Dec 2025, up 167.21% year-over-year, with the annual reading at $0.78 for FY2025, 144.07% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $0.33 in Q4 2025 for Guardian Pharmacy Services, up from $0.15 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.33 in Q4 2025 to a low of -$2.0 in Q3 2024.